Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Chemed Corporation (CHE : NYSE)
 
 • Company Description   
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.

Number of Employees: 15,695

 
 • Price / Volume Information   
Yesterday's Closing Price: $457.89 Daily Weekly Monthly
20 Day Moving Average: 167,896 shares
Shares Outstanding: 14.57 (millions)
Market Capitalization: $6,672.23 (millions)
Beta: 0.46
52 Week High: $623.61
52 Week Low: $408.42
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 3.16% 1.30%
12 Week -16.15% -23.87%
Year To Date -13.57% -22.83%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
255 EAST FIFTH STREET SUITE 2600
-
CINCINNATI,OH 45202
USA
ph: 513-762-6690
fax: 513-762-6590
None http://www.chemed.com
 
 • General Corporate Information   
Officers
Kevin J. McNamara - President and Chief Executive Officer
Michael D. Witzeman - Vice President; Chief Financial Officer; and Contr
Ron DeLyons - Directors
Patrick P. Grace - Directors
Christopher J. Heaney - Directors

Peer Information
Chemed Corporation (CMTI)
Chemed Corporation (CMWLQ)
Chemed Corporation (AHG.)
Chemed Corporation (ROIX)
Chemed Corporation (M.DCE)
Chemed Corporation (DHSM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-OUTP/HM CRE
Sector: Medical
CUSIP: 16359R103
SIC: 8082
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/04/25
Share - Related Items
Shares Outstanding: 14.57
Most Recent Split Date: 5.00 (2.00:1)
Beta: 0.46
Market Capitalization: $6,672.23 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.52%
Current Fiscal Quarter EPS Consensus Estimate: $4.85 Indicated Annual Dividend: $2.40
Current Fiscal Year EPS Consensus Estimate: $20.06 Payout Ratio: 0.10
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.02
Estmated Long-Term EPS Growth Rate: 8.56% Last Dividend Paid: 08/11/2025 - $0.60
Next EPS Report Date: 11/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 22.82
Trailing 12 Months: 22.35
PEG Ratio: 2.66
Price Ratios
Price/Book: 5.57
Price/Cash Flow: 17.81
Price / Sales: 2.66
EPS Growth
vs. Year Ago Period: -25.15%
vs. Previous Quarter: -26.61%
Sales Growth
vs. Year Ago Period: 3.85%
vs. Previous Quarter: -4.35%
ROE
06/30/25 - 25.83
03/31/25 - 27.58
12/31/24 - 27.27
ROA
06/30/25 - 17.77
03/31/25 - 18.96
12/31/24 - 18.75
Current Ratio
06/30/25 - 1.86
03/31/25 - 1.73
12/31/24 - 1.38
Quick Ratio
06/30/25 - 1.83
03/31/25 - 1.70
12/31/24 - 1.35
Operating Margin
06/30/25 - 12.17
03/31/25 - 13.14
12/31/24 - 13.31
Net Margin
06/30/25 - 11.56
03/31/25 - 12.40
12/31/24 - 12.42
Pre-Tax Margin
06/30/25 - 15.44
03/31/25 - 16.50
12/31/24 - 16.43
Book Value
06/30/25 - 82.25
03/31/25 - 80.78
12/31/24 - 74.35
Inventory Turnover
06/30/25 - 190.32
03/31/25 - 177.22
12/31/24 - 159.53
Debt-to-Equity
06/30/25 - 0.00
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - 0.00
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©